IP Library Granted Patent US 7,102,013
Granted Patent B2
US 7,102,013 · App. 10/321,969 · Granted Sep 5, 2006

Methods of making amidino compounds useful as nitric oxide synthase inhibitors

Assignee: Pharmacia Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,102,013
App. No.
10/321,969
Granted
Sep 5, 2006
Kind
B2
Abstract

Method of making an alpha-amino acid compound having the structure of Formula 32: comprising treating under hydrolyzing conditions a hydantoin compound having the structure of Formula 33: where the substituents are described herein.

Claims (34)

1. A method for the preparation of an alpha-amino acid compound having the structure of Formula 32:

or a salt, an enantiomer, or a racemate thereof, wherein:

R 2 is selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 5 alkoxy-C 1 alkyl, and C 1 -C 5 alkylthio-C 1 alkyl;

R 1 , R 5 , R 6 , and R 7 independently are selected from the group consisting of —H, halogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, and C 1 -C 5 alkoxy-C 1 alkyl;

R 9 and R 10 independently are selected from the group consisting of —H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, and C 1 -C 5 alkoxy-C 1 alkyl; and

when any of R 1 , R 2 , R 5 , R 6 , R 7 , R 9 , and R 10 independently is a moiety selected from the group consisting of alkyl, alkenyl, and alkynyl, then the moiety is optionally substituted by one or more substituent selected from the group consisting of —OH, alkoxy, and halogen;

wherein the method comprises hydrolyzing a hydantoin compound having the structure of Formula 33:

 or a salt, an enantiomer, or a racemate thereof, thereby forming the alpha-amino acid compound.

2. The method of claim 1 wherein the hydrolyzing conditions comprise contacting the hydantoin compound with an acid to produce an acid hydrolyzate.

3. The method of claim 2 wherein the acid is selected from the group consisting of hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, trifluoroacetic acid, and phosphoric acid.

4. The method of claim 2 wherein the method further comprises treating the acid hydrolyzate with an ion exchange resin.

5. The method of claim 1 wherein the hydrolyzing conditions comprise contacting the hydantoin compound with a base to produce a base hydrolyzate.

6. The method of claim 5 wherein the base is selected from the group consisting of a hydrazine, a metal sulfide, a metal hydroxide, and a metal alkoxide.

7. The method of claim 1 wherein R 1 , R 5 , R 6 , and R 7 each is —H.

8. The method of claim 1 wherein R 9 and R 10 each is —H.

9. The method of claim 1 where the alpha-amino acid compound has the structure of Formula 34:

or a salt, an enantiomer, or a racemate thereof.

10. A method for the preparation of a hydantoin compound having the structure of Formula 35:

or a salt, an enantiomer, or a racemate thereof, wherein:

R 2 is selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 5 alkoxy-C 1 alkyl, and C 1 -C 5 alkylthio-C 1 alkyl;

R 1 , R 5 , R 6 , and R 7 independently are selected from the group consisting of —H, halogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, and C 1 -C 5 alkoxy-C 1 alkyl;

R 9 and R 10 independently are selected from the group consisting of —H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, and C 1 -C 5 alkoxy-C 1 alkyl; and

when any of R 1 , R 2 , R 5 , R 6 , R 7 , R 9 , and R 10 independently is a moiety selected from the group consisting of alkyl, alkenyl, and alkynyl, then the moiety is optionally substituted by one or more substituent selected from the group consisting of —OH, alkoxy, and halogen;

wherein the method comprises contacting an alpha-sulfo ketone compound having the structure of Formula 36:

 with a source of cyanide in the presence of a source of ammonium carbonate and water, thereby producing the hydantoin compound.

11. The method of claim 10 wherein the source of cyanide is hydrogen cyanide.

12. The method of claim 10 wherein the source of cyanide is a metal cyanide salt.

13. The method of claim 12 wherein the metal cyanide salt is selected from the group consisting of sodium cyanide, potassium cyanide, and lithium cyanide.

14. The method of claim 13 wherein the metal cyanide salt is sodium cyanide.

15. The method of claim 10 wherein R 1 , R 5 , R 6 , and R 7 each is —H.

16. The method of claim 10 wherein R 9 and R 10 each is —H.

17. The method of claim 10 further comprising a chiral separation step.

18. The method of claim 17 wherein the hydantoin compound has the structure of Formula 33:

or a salt or an enantiomer thereof.

Assignments (1)
CHANGE OF NAME Recorded Dec 6, 2012
From: PHARMACIA CORPORATION
To: PHARMACIA LLC
Reel/Frame 029416/0192 →
Continuity (3)
Division 0981657500 · Mar 23, 2001
Provisional Application 6019192300 · Mar 24, 2000
Related Publication 20030199701A1 · Oct 23, 2003